Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
5.08
-0.03 (-0.59%)
Jan 9, 2026, 4:00 PM EST - Market closed
Evaxion Market Cap
Evaxion has a market cap or net worth of $42.37 million as of January 12, 2026. Its market cap has increased by 695.71% in one year.
Market Cap
42.37M
Enterprise Value
31.80M
1-Year Change
695.71%
Ranking
Category
Stock Price
$5.08
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $42.37M, a decrease of -77.93%. That is a compound annual growth rate of -26.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 42.37M | 6.50% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | 191.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |